- Home
- LTRN vs FAAS Comparison
LTRN vs FAAS Comparison
Compare LTRN & FAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- FAAS
- Stock Information
- Founded
- LTRN 2013
- FAAS 2021
- Country
- LTRN United States
- FAAS Indonesia
- Employees
- LTRN N/A
- FAAS N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- FAAS
- Sector
- LTRN Health Care
- FAAS
- Exchange
- LTRN Nasdaq
- FAAS NYSE
- Market Cap
- LTRN 36.1M
- FAAS 34.6M
- IPO Year
- LTRN 2020
- FAAS N/A
- Fundamental
- Price
- LTRN $3.32
- FAAS $0.72
- Analyst Decision
- LTRN Strong Buy
- FAAS
- Analyst Count
- LTRN 1
- FAAS 0
- Target Price
- LTRN $25.00
- FAAS N/A
- AVG Volume (30 Days)
- LTRN 67.8K
- FAAS 53.5M
- Earning Date
- LTRN 05-15-2025
- FAAS 01-01-0001
- Dividend Yield
- LTRN N/A
- FAAS N/A
- EPS Growth
- LTRN N/A
- FAAS N/A
- EPS
- LTRN N/A
- FAAS N/A
- Revenue
- LTRN N/A
- FAAS $57,730,593.00
- Revenue This Year
- LTRN N/A
- FAAS N/A
- Revenue Next Year
- LTRN N/A
- FAAS N/A
- P/E Ratio
- LTRN N/A
- FAAS N/A
- Revenue Growth
- LTRN N/A
- FAAS 38.16
- 52 Week Low
- LTRN $2.55
- FAAS $0.16
- 52 Week High
- LTRN $6.12
- FAAS $8.49
- Technical
- Relative Strength Index (RSI)
- LTRN 47.70
- FAAS 54.73
- Support Level
- LTRN $2.85
- FAAS $0.47
- Resistance Level
- LTRN $3.48
- FAAS $1.59
- Average True Range (ATR)
- LTRN 0.26
- FAAS 0.29
- MACD
- LTRN 0.01
- FAAS -0.01
- Stochastic Oscillator
- LTRN 53.41
- FAAS 32.54
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About FAAS DIGIASIA CORP
DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.